首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics:I.Identification of Polymorphisms in the 5'-Regulatory and Exon 1 Regions,and Association with Human Liver UGT1A6 Gene Expression and Glucuronidation
【24h】

UDP Glucuronosyltransferase (UGT) 1A6 Pharmacogenetics:I.Identification of Polymorphisms in the 5'-Regulatory and Exon 1 Regions,and Association with Human Liver UGT1A6 Gene Expression and Glucuronidation

机译:UDP葡萄糖醛糖基转移酶(UGT)1A6药理遗传学:I。5'-调节和外显子1区多态性的鉴定,并与人肝UGT1A6基因表达和葡萄糖醛酸化相关

获取原文
获取原文并翻译 | 示例
           

摘要

UDP glucuronosyltransferase (UGT) 1A6 is a major isoform in human liver that glucuronidates numerous drugs,toxins,and endogenous substrates with high interindividual variability.The molecular basis for this variability remains unknown,although it likely involves genetic and environmental factors.Phenotype-genotype studies were conducted using a well characterized human liver bank (n = 54) and serotonin glucuronidation as a UGT1A6-specific phenotype marker.A positive moderate-to-heavy alcohol use history (>14 drinks per week) was the only demographic factor examined that correlated with phenotype and was associated with 2-fold higher serotonin glucuronidation (p < 0.001),UGT1A6 protein content (p = 0.004),and UGT1A6 mRNA content (p = 0.025).UGT1A6 gene resequenc-ing identified three nonsynonymous polymorphisms (S7A,T181 A,and R184S) in exon 1 and eight novel polymorphisms in the 5'-regulatory region (to -2052 base pairs).S7A was in complete linkage disequilibrium with three 5'-regulatory region polymorphisms (-1710c->g,-1310del5,and -652g->a).Initial univariate analyses did not identify any significant pheno-type-genotype associations.However,in livers without substantial alcohol exposure,50% lower UGT1A6 mRNA levels (p = 0.026) were found in carriers of the linked S7A-enhancer polymorphisms compared with noncarriers but without significant effect on UGT1A6 protein content or glucuronidation activities.Three major haplotypes,including *1A (reference),*1B (-1535g->a and -427g->c),and *2 (-1710c-*g,-1310del5,-652g->a,S7A,T181A,and R184S),were identified,accounting for 90% of alleles.No association of haplotype with any of the phenotype measures could be discerned.In conclusion,although the identified UGT1A6 polymorphisms did not explain the observed glucuronidation variability,there does seem to be a significant role for environmental factors associated with alcohol consumption.
机译:UDP葡萄糖醛酸糖基转移酶(UGT)1A6是人肝脏中的主要同工型,可葡萄糖苷酸化许多药物,毒素和内源底物,具有很高的个体差异性。尽管存在遗传和环境因素,但这种差异性的分子基础仍然未知。表型-基因型研究使用特征明确的人肝储备库(n = 54)和血清素葡萄糖醛酸化作为UGT1A6特异性表型标记进行。中度至重度酒精使用史(每周> 14酒)为阳性,是唯一相关的人口统计学因素与表型相关,并与5-羟色胺葡萄糖醛酸化率高2倍(p <0.001),UGT1A6蛋白含量(p = 0.004)和UGT1A6 mRNA含量(p = 0.025)相关.UGT1A6基因重排确定了三个非同义多态性(S7A,T181外显子1中的A和R184S以及5'调控区(至-2052个碱基对)中的8个新的多态性。S7A与3个5'调控区完全连锁不平衡y区多态性(-1710c-> g,-1310del5和-652g-> a)。最初的单变量分析未发现任何显着的表型-基因型关联。但是,在没有大量酒精暴露的肝脏中,UGT1A6 mRNA降低了50%与非携带者相比,与S7A增强多态性连锁的携带者体内水平(p = 0.026),但对UGT1A6蛋白含量或葡萄糖醛酸化活性没有明显影响。三种主要单倍型,包括* 1A(参考),* 1B(-1535g-> a和-427g-> c)和* 2(-1710c- * g,-1310del5,-652g-> a,S7A,T181A和R184S),占等位基因的90%。总之,尽管确定的UGT1A6多态性不能解释观察到的葡萄糖醛酸化变异性,但似乎对与饮酒有关的环境因素起着重要作用。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号